Reference health

Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study

https://doi.org/10.1016/j.atherosclerosis.2006.04.006
CiteStamped reference-health badge
26/26 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 26 checked references that resolve
resolves10.1111/j.1440-1746.2004.03312.x
Non‐alcoholic steatohepatitis in type 2 diabetes mellitus
resolves10.1016/S1542-3565(04)00014-X
Nonalcoholic fatty liver disease in patients with type 2 diabetes
resolves10.1016/S0261-5614(99)80015-6
Non-alcoholic fatty liver: another feature of the metabolicsyndrome?
resolves10.1093/qjmed/92.2.73
Fatty liveran additional and treatable feature of the insulin resistance syndrome
resolves10.1007/s00125-004-1460-1
Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk
resolves10.2337/diabetes.53.11.2855
Elevated Alanine Aminotransferase Predicts New-Onset Type 2 Diabetes Independently of Classical Risk Factors, Metabolic Syndrome, and C-Reactive Protein in the West of Scotland Coronary Prevention Study
resolves10.2337/diabetes.51.6.1889
High Alanine Aminotransferase Is Associated With Decreased Hepatic Insulin Sensitivity and Predicts the Development of Type 2 Diabetes
resolves10.1161/CIRCULATIONAHA.104.516948
Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study
resolves10.1111/j.1365-2362.2005.01502.x
Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus
resolves10.1161/01.ATV.0000160613.57985.18
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis
resolves10.2337/diacare.18.9.1270
Prevalence and Determinants of Glucose Intolerance in a Dutch Caucasian Population: The Hoorn Study
resolves10.7326/0003-4819-137-1-200207020-00012
Alanine Aminotransferase Levels: What's Normal?
resolves10.1002/hep.20187
The elusiveness of “normal” ALT in fatty liver
resolves10.1007/BF00280883
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
resolves10.1016/0895-4356(95)00013-T
A semiquantitative food frequency questionnaire for use in epidemiologic research among the elderly: Validation by comparison with dietary history
resolves10.1016/0002-8703(88)90891-5
Cardiac failure and sudden death in the Framingham Study
resolves10.1007/s004200050299
Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality
resolves10.1053/meta.2002.34046
A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients
resolves10.2337/diacare.27.10.2498
Relation of Nonalcoholic Hepatic Steatosis to Early Carotid Atherosclerosis in Healthy Men
resolves10.1161/01.CIR.0000140762.04598.F9
National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study
resolves10.1152/ajpendo.2001.280.5.E745
Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
resolves10.1016/S0895-4356(01)00502-9
C-reactive protein and myocardial infarction
resolves10.1056/NEJM200003233421202
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
resolves10.1146/annurev.med.53.082901.104057
Lipotoxic Diseases
resolves10.1097/00005176-200301000-00012
The Spectrum of Fatty Liver in Obese Children and The Relationship of Serum Aminotransferases to Severity of Steatosis
resolves10.1111/j.1572-0241.1999.01451.x
Prospective Evaluation of Unexplained Chronic Liver Transaminase Abnormalities in Asymptomatic and Symptomatic Patients
The 2 references without a DOI — listed, not checked
no DOI — not checked10.1016/j.atherosclerosis.2006.04.006_bib12
no DOI — not checkedAssociation between elevated liver enzymes and C-reactive protein. possible hepatic contribution to systemic inflammation in the metabolic syndrome
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.atherosclerosis.2006.04.006"><img src="https://citestamp.com/citestamped/10.1016/j.atherosclerosis.2006.04.006/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.atherosclerosis.2006.04.006/badge.svg)](https://citestamp.com/citestamped/10.1016/j.atherosclerosis.2006.04.006)